We used logistic regression analysis to investigate the relationship between serum anti-Mullerian hormone (AMH) levels and the rate of ongoing pregnancy. Retrospective data were collected from 1043 women who had undergone their first cycle of in vitro fertilization (IVF), including 540 cycles of fresh embryo transfer and 503 cycles of frozen-thawed embryo transfer. The patients were divided into 4 groups based on the cutoff values from a receiver–operating characteristic curve: 0.0 to 12.4, 12.5 to 25.5, 25.6 to 44.1, and >44.2 pmol/L. After adjustment for multiple confounders, the serum AMH group was found to be significantly related to the rate of ongoing pregnancy in total cycles (0.0-12.4 vs 12.5-25.5 pmol/L; P = .0088, odds ratio, 1.909: vs 25.6-44.1 pmol/L; P = .0281, odds ratio, 2.109: vs >44.2 pmol/L; P = .0008, odds ratio, 2.840). In conclusion, there appears to be a significant relationship between serum AMH levels and the ongoing pregnancy rate in first IVF treatment cycles after adjustment for multiple confounders.
FanchinRMendez LozanoDHFrydmanNAnti-Mullerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization. J Clin Endocrinol Metab. 2007;92(5):1796–1802.
2.
TakahashiCFujitoAKazukaMSugiyamaRItoHIsakaK. Anti-Mullerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilization. Fertil Steril. 2008;89(3):586–591.
3.
SilbersteinTMacLaughlinDTShaiIMullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology. Hum Reprod. 2006;21(1):159–163.
4.
NelsonSMYatesRWLyallHAnti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum Reprod. 2009;24(4):867–875.
5.
KiniSLiHWMorrellDPickeringSThongKJ.Anti-mullerian hormone and cumulative pregnancy outcome in in-vitro fertilization. J Assist Reprod Genet. 27(8):449–456.
6.
BlazarASLambert-MesserlianGHackettRKrotzSCarsonSARobinsJC.Use of in-cycle antimullerian hormone levels to predict cycle outcome. Am J Obstet Gynecol. 2011;205(3):223.e1–e5.
7.
La MarcaASighinolfiGRadiDAnti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16(2):113–130.
8.
Lie FongSBaartEBMartiniEAnti-Mullerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality?Reprod Biomed Online. 2008;16(5):664–670.
9.
GuerifFLemsefferMCouetMLGervereauORactVRoyereD. Serum antimullerian hormone is not predictive of oocyte quality in vitro fertilization. Ann Endocrinol (Paris). 2009;70(4):230–234.
10.
RiggsRKimbleTOehningerSAnti-Mullerian hormone serum levels predict response to controlled ovarian hyperstimulation but not embryo quality or pregnancy outcome in oocyte donation. Fertil Steril. 2011;95(1):410–412.
11.
EndoTHonnmaHHayashiTContinuation of GnRH agonist administration for 1 week, after hCG injection, prevents ovarian hyperstimulation syndrome following elective cryopreservation of all pronucleate embryos. Hum Reprod. 2002;17(10):2548–2551.
12.
ShapiroBSDaneshmandSTGarnerFCAguirreMHudsonCThomasS. Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfers in high responders. Fertil Steril. 2011;96(2):516–518.
13.
LekamgeDNBarryMKoloMLaneMGilchristRBTremellenKP. Anti-Mullerian hormone as a predictor of IVF outcome. Reprod Biomed Online. 2007;14(5):602–610.
14.
HonnmaHBabaTSasakiMDifferent ovarian response by age in an anti-Müllerian hormone-matched group undergoing in vitro fertilization. J Assist Reprod Genet. 2011; 29(2):117–125
15.
HonnmaHHashibaYAsadaYEndoT. Failure of triggering oocyte maturation with a GnRH agonist in polycystic ovary syndrome: two case reports. Eur J Obstet Gynecol Reprod Biol. 2011;157(2):239–240.
16.
VeeckLL. Oocyte assessment and biological performance. Ann N Y Acad Sci. 1988;541:259–274.
17.
GotoSKadowakiTTanakaSHashimotoHKokeguchiSShiotaniM. Prediction of pregnancy rate by blastocyst morphological score and age, based on 1,488 single frozen-thawed blastocyst transfer cycles. Fertil Steril. 2011;95(3):948–952.
BancsiLFHuijsAMden OudenCTBasal follicle-stimulating hormone levels are of limited value in predicting ongoing pregnancy rates after in vitro fertilization. Fertil Steril. 2000;73(3):552–557.
20.
GnothCSchuringANFriolKTiggesJMallmannPGodehardtE. Relevance of anti-Mullerian hormone measurement in a routine IVF program. Hum Reprod. 2008;23(6):1359–1365.
21.
LiHWYeungWSLauEYHoPCNgEH. Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine insemination. Fertil Steril. 2010;94(6):2177–2181.
22.
WeghoferADietrichWBaradDHGleicherN. Live birth chances in women with extremely low-serum anti-Mullerian hormone levels. Hum Reprod. 2011;26(7):1905–1909.
23.
WangJGDouglasNCNakhudaGSThe association between anti-Mullerian hormone and IVF pregnancy outcomes is influenced by age. Reprod Biomed Online. 2010;21(6):757–761.
24.
EbnerTSommergruberMMoserMSheblOSchreier-LechnerETewsG. Basal level of anti-Mullerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod. 2006;21(8):2022–2026.
25.
HaadsmaMLMooijTMGroenHA reduced size of the ovarian follicle pool is associated with an increased risk of a trisomic pregnancy in IVF-treated women. Hum Reprod. 2010;25(2):552–558.
26.
van der StroomEMKonigTEvan Dulmen-den BroederEEarly menopause in mothers of children with Down syndrome?Fertil Steril. 2011;96(4):985–990.
27.
KlineJKKinneyAMLevinBKellyACFerinMWarburtonD. Trisomic pregnancy and elevated FSH: implications for the oocyte pool hypothesis. Hum Reprod. 2011;26(6):1537–1550.
